Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
FLGT compared with AKBA: revenue, margins and what each company keeps, and the suppliers and customers both name
FLGT
Fulgent Genetics, Inc.
Change
Mkt cap
Revenue
Revenue
AKBA
Akebia Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
FLGT
Fulgent Genetics, Inc.
vs
AKBA
Akebia Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
FLGT
with
AKBA
No shared trading history for FLGT and AKBA.
No shared co-movers.
FLGT, solid
AKBA, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
FLGT
Fulgent Genetics, Inc.
Change
19.26
▼
−6.62%
Mkt cap
$567.4M
Revenue
$85M
Q2 FY26
Revenue
$323M
FY25
AKBA
Akebia Therapeutics, Inc.
Change
0.70
▼
−1.46%
Regular session
Nov 2 '26
Mkt cap
$195.8M
Revenue
$49M
Q2 FY26
Revenue
$236M
FY25
vs
Compare
Regular session
Nov 2 '26
FLGT
Fulgent Genetics, Inc.
vs
AKBA
Akebia Therapeutics, Inc.
19.26
▼
−6.62%
Price
0.70
▼
−1.46%
$567.4M
Mkt cap
$195.8M
Q2 FY26
$85M
Revenue
$49M
Q2 FY26
FY25
$323M
Revenue
$236M
FY25
Change
Change
FLGT
19.26
▼
−6.62%
vs
AKBA
0.70
▼
−1.46%
Regular session
Nov 2 '26